Purchase Order HHSN272201501047P
Award Date 8/11/15
Potential Completion Date 8/18/15
Potential Value $8.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina Next Generation Sequencing (NGS) Kits. The contract has a ceiling value of $14,284.57 and a completion date of September 11, 2015. Illumina is a manufacturer of sequencing and array-based genomic analysis solutions, and has previously received other prime federal...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for Illumina HiSeq library preparation and cluster kits. The award has a ceiling value of $3,144 and was made on a non-set-aside basis. Illumina is a manufacturer and provider of genetic and genomic analysis solutions, including a range of DNA sequencing instruments and reagents used across federal...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for cycles of DNA sequencing services. The contract has a ceiling value of $5,548.11 and a completion date of September 3, 2013. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has provided a range of sequencing systems and related products to support...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for the provision of SEQUENCING KITS. The contract has a ceiling value of $4,317.81 and an ultimate completion date of July 30, 2015. There was no set-aside designation for this award. Illumina, a for-profit organization, has a history of providing a range of sequencing...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Illumina, Inc. for sequencing kits to support the Illumina HiSeq 2500 gene sequencing platform. The total award ceiling is $19,450.92, with an ultimate completion date of April 24, 2015. Illumina is a for-profit manufacturer of genetic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and...
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of consumables to support Illumina's genetic sequencing equipment. The contract has a total ceiling value of $108,694.36 and a completion date of November 16, 2021. Illumina is a manufacturer of sequencing and analysis solutions for life science research, applied markets, and molecular...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award, valued at $5,277.25, is for the provision of sequencing kits to support NIAID's research and diagnostics work. Illumina has been a long-standing provider of sequencing solutions to various federal agencies including the Centers for...
- This is a $8,080.64 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is not associated with a set-aside program. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and diagnostics for various federal agencies including the NIH, CDC, USDA, and VA. This particular...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...